Zee Wan Wong

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 854 citations

End-of-study Results, Breast Oncology, Medicine +8

Influence of <i>ABCB1</i> and <i>ABCG2</i> polymorphisms on doxorubicin disposition in Asian breast cancer patients

Suman Lal, Zee Wan Wong, Edwin Sandanaraj et al. · Cancer Science · 2008 · 133 citations · Full text

Novel <i>SLC22A16</i> Polymorphisms and Influence on Doxorubicin Pharmacokinetics in Asian Breast Cancer Patients

Suman Lal, Zee Wan Wong, Srinivasa Rao Jada et al. · Pharmacogenomics · 2007 · 92 citations

<i>CBR1</i>and<i>CBR3</i>pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients

Suman Lal, Edwin Sandanaraj, Zee Wan Wong et al. · Cancer Science · 2008 · 76 citations · Full text

<i>PXR</i> Pharmacogenetics: Association of Haplotypes with Hepatic <i>CYP3A4</i> and <i>ABCB1</i> Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients

Edwin Sandanaraj, Suman Lal, Viknesvaran Selvarajan et al. · Clinical Cancer Research · 2008 · 69 citations